Market revenue in 2023 | USD 8,228.4 million |
Market revenue in 2030 | USD 11,394.3 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 69.8% in 2023. Horizon Databook has segmented the Germany active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of key market players in Germany and an increasing focus on geographic expansion with product launches are factors driving the API market in Germany. For instance, in May 2020, Evonik invested approximately USD 30 million to expand the capacity of its German API facility to meet the region's future API demands.
Germany is considered as a leader in API production in Europe. However, the country is reliant on Asia for 63% of its API raw material requirements. In February 2021, BioNTech announced its new production facility for mRNA, which is used as an API in COVID-19 vaccines in Marburg, Germany.
The facility is expected to be the largest in Europe and is projected to help produce over 750 million dosages of vaccine with mRNA. High demand for vaccines is expected to drive market growth in Germany in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Germany active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account